Phytotherapeutics in psychiatry

Therapeutische Umschau

Volumn 59, Issue 6, 2002, Pages 307-312

  Kalus, P ^a   Strik, W K ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

GINKGO BILOBA EXTRACT; HERBACEOUS AGENT; KAVA EXTRACT; VALERIAN; PLANT EXTRACT; PSYCHOTROPIC AGENT;

ALTERNATIVE MEDICINE; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG INDICATION; DRUG SAFETY; HUMAN; HYPERICUM PERFORATUM; MEDICAL LITERATURE; MEDICAL RESEARCH; MENTAL DISEASE; CLINICAL TRIAL; COMPARATIVE STUDY; PHYTOTHERAPY; PSYCHOLOGICAL ASPECT; TREATMENT OUTCOME;

CLINICAL TRIALS; HUMANS; MENTAL DISORDERS; PHYTOTHERAPY; PLANT EXTRACTS; PSYCHOTROPIC DRUGS; TREATMENT OUTCOME;

EID: 0036599408     PISSN: 00405930     EISSN: None     Source Type: Journal    
DOI: 10.1024/0040-5930.59.6.307     Document Type: Article

References (50)

1. Unconventional medicine in the United States: Prevalence, costs and patterns of use
2. Alternative medicine: What pharmacists need to know
3. Psychiatrists' experience and view regarding St. John's wort and «alternative» treatments
4. Efficacy and safety of St. John's wort for the treatment of major depression
5. Pflanzenheilmittel und seelische Störungen
6. St. John's wort (Hypericum perforatum): A review of the current pharmacological, toxicological and clinical literature
7. Effects of Hypericum extract (LI 160) in biochemical models of anti-depressant activity
8. Zum Wirkungs-mechanismus von Johanniskraut-Extrakt
9. Modulation of cytokine expression by Hypericum extract
10. Neurotransmitter regulation of anterior pituitary hormones
11. Effect of Hypericum perforatum on salivary cortisol in healthy male volunteers
12. Neuroendocrine evidence for dopaminergic actions of Hypericum extract (LI 160) in healthy volunteers
13. The scientific, quasi-scientific and popular literature on the use of St. John's wort in the treatment of depression
14. St. John's wort for depression: An overview and meta-analysis of randomized clinical trials
15. St. John's wort for depression: A meta-analysis of well-defined clinical trials
16. 2000. St. John's wort for depression: A systematic review
17. Effectiveness and tolerance of the hypericum extract LI 160 compared to maprotiline: A multicenter double-blind study
18. LI 160, an extract of St. John's wort, versus amitriptyline in mildly to moderately depressed outpatients - A controlled 6-week clinical trial
19. Comparison of St. John's wort and imipramine for treating depression: Randomized controlled trial
20. Efficacy and tolerability of St. John's wort extract LI 160 versus imipramine in patients with severe depressive episodes according to ICD-10
21. Comparison of equivalence between the St. John's wort extract LoHyp and fluoxetine
22. Equivalence of St. John's wort extract (Ze 117) and fluoxetine: A randomized, controlled study in mild to moderate depression
23. Adverse effects profile of the herbal antidepressant St. John's wort (Hypericum perforatum)
24. St. John's wort: Effect on CYP3A4 activity
25. Pharmacology of kava
26. Extract of kava (Piper methysticum) and its methysticin constituents protect brain tissue against ischemia damage in rodents
27. Kava extract ingredients, (+)-methysticin and (±)-kavain inhibit voltage-operated Na(+)-channels in rat CA1 hippocampal neurons
28. Kavapyrone enriched extract from Piper metLysticum as modulator of the GABA binding site in different regions of rat brain
29. Efficacy of kava extract for treating anxiety: Systematic review and meta-analysis
30. Kava: An overview
31. Nekrotisierende Hepatitis nach Einnahme pflanzlicher Heilmittel
32. Effect of valerian on human sleep
33. Critical evaluation of the effect of valerian extract on sleep structure and sleep quality
34. Wirksamkeit und Vertäglichkeit von Baldrian versus Oxazepam bei nichtorganischen und nichtpsychiatrischen Insomnien: Eine randomisierte, doppelblinde, klinische Vergleichsstudie
35. Valerian overdose: A case report
36. Gingko biloba
37. A placebo-controlled, double-blind, randomized trial of an extract of Gingko biloba for dementia
38. Cholinesterase inhibitors and Gingko extracts - Are they comparable in the treatment of dementia?
39. Subarachnoid haemorrhage associated with Gingko biloba
40. Gingko biloba: A case report of herbal medicine and bleeding postoperatively from a laparoscopic cholecystectomy
41. Kompendium der Psychiatrischen Pharmakotherapie
42. Apigenin, a component of Matricaria recutita flowers, is a central benzodiazepine receptors ligand with anxiolytic effects
43. Effects of some components of the essential oil of chamomile, Chamomilla recutita, on histamine release from rat mast cells
44. The chamomiles
45. Narcotic action of 2-methyl-3-butene-2-ol contained in the exhalation of hops
46. Neurotropic action of the hydroalcoholic extract of Melissa officinalis in the mouse
47. A combination of plant extracts in the treatment of outpatients with adjustment disorder with anxious mood: A controlled study versus placebo